Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UROY
11526
Uranium Royalty Corp
UROY
$1.65B
| $103K | ﹤0.01% |
+58,257
| New | +$125K |
|
11527
MIND Technology
MIND
$40.4M
| $102K | ﹤0.01% |
+17,060
| New | +$137K |
|
11528
PUT
Gerdau
GGB
$9.22B
| $102K | ﹤0.01% |
36,000
-16,500
| -31% | -$48.2K |
|
|
RMAX
11529
PUT
DELISTED
RE/MAX Holdings
RMAX
| $102K | ﹤0.01% |
+12,200
| New | +$116K |
|
11530
ICL Group
ICL
$7.32B
| $102K | ﹤0.01% |
17,936
-73,496
| -80% | -$433K |
|
11531
CALL
Jasper Therapeutics
JSPR
$23.3M
| $102K | ﹤0.01% |
23,700
-20,600
| -47% | -$137K |
|
|
CIO
11532
CALL
DELISTED
City Office REIT
CIO
| $101K | ﹤0.01% |
+19,500
| New | +$100K |
|
11533
WidePoint Corp
WYY
$102M
| $101K | ﹤0.01% |
30,367
-12,373
| -29% | -$47K |
|
|
PCF
11534
High Income Securities Fund
PCF
$101M
| $101K | ﹤0.01% |
15,185
-1,926
| -11% | -$12.9K |
|
11535
Golden Heaven Group Holdings
GDHG
$77.3M
| $101K | ﹤0.01% |
+57
| New | +$39.5K |
|
|
MBX
11536
MBX Biosciences
MBX
$3.2B
| $101K | ﹤0.01% |
+13,660
| New | +$144K |
|
11537
CALL
AirSculpt Technologies
AIRS
$188M
| $101K | ﹤0.01% |
43,000
+13,100
| +44% | +$58.8K |
|
11538
CALL
Tyra Biosciences
TYRA
$1.56B
| $100K | ﹤0.01% |
+10,800
| New | +$140K |
|
|
ABX
11539
CALL
Abacus Global Management
ABX
$961M
| $100K | ﹤0.01% |
+13,400
| New | +$102K |
|
11540
PUT
Asure Software
ASUR
$259M
| $100K | ﹤0.01% |
10,500
+500
| +5% | +$5.48K |
|
11541
CALL
Ocugen
OCGN
$465M
| $100K | ﹤0.01% |
141,100
+115,500
| +451% | +$79.9K |
|
11542
CPI Aerostructures
CVU
$70.8M
| $100K | ﹤0.01% |
28,806
+2,445
| +9% | +$10.4K |
|
|
BIOA
11543
BioAge Labs
BIOA
$463M
| $99.7K | ﹤0.01% |
+26,520
| New | +$123K |
|
|
AEVA
11544
PUT
Aeva Technologies
AEVA
$1.14B
| $99.4K | ﹤0.01% |
+14,200
| New | +$58.5K |
|
|
CIO
11545
PUT
DELISTED
City Office REIT
CIO
| $99.1K | ﹤0.01% |
19,100
+7,300
| +62% | +$37.5K |
|
11546
US Global Investors
GROW
$41.6M
| $99.1K | ﹤0.01% |
43,862
-617
| -1% | -$1.47K |
|
|
ILPT
11547
CALL
Industrial Logistics Properties Trust
ILPT
$555M
| $98.4K | ﹤0.01% |
28,600
-53,100
| -65% | -$198K |
|
11548
United-Guardian
UG
$33.1M
| $98.3K | ﹤0.01% |
+10,933
| New | +$112K |
|
11549
PUT
Cardiff Oncology
CRDF
$76.7M
| $98.3K | ﹤0.01% |
31,300
-13,700
| -30% | -$54.2K |
|
|
CMPS
11550
PUT
Compass Pathways
CMPS
$2.03B
| $98.1K | ﹤0.01% |
+34,300
| New | +$132K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.